1. Home
  2. ASLE vs CRDL Comparison

ASLE vs CRDL Comparison

Compare ASLE & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$4.76

Market Cap

242.5M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

BUY

Current Price

$1.17

Market Cap

226.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ASLE
CRDL
Founded
2008
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.5M
226.6M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
ASLE
CRDL
Price
$4.76
$1.17
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$7.25
★ $8.42
AVG Volume (30 Days)
473.7K
★ 1.5M
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.64
N/A
EPS
N/A
★ N/A
Revenue
★ $335,286,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.68
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.71
$0.88
52 Week High
$8.04
$2.34

Technical Indicators

Market Signals
Indicator
ASLE
CRDL
Relative Strength Index (RSI) 30.77 22.26
Support Level $4.71 $0.96
Resistance Level $5.90 $1.35
Average True Range (ATR) 0.16 0.08
MACD -0.02 -0.04
Stochastic Oscillator 3.59 1.34

Price Performance

Historical Comparison
ASLE
CRDL

About ASLE AerSale Corporation

AerSale Corp offers full-service support to owners and operators of mid-life commercial aircraft. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing various maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. AerSale also offers asset management services to owners of end-of-life aircraft and engine portfolios. The company has two reportable segments: Asset Management Solutions and TechOps. Maximum revenue is generated from the Asset Management Solutions segment, which comprises activities to extract value from strategic asset acquisitions through leasing, trading, or disassembling for product sales. Geographically, the company derives maximum revenue from its domestic market.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: